Curefoods India IPO

Initial public offering of [] equity shares of face value of Re.1/- each (Equity Shares) of Curefoods India Limited (the Company or the Issuer) for cash at a price of Rs. [] per equity share including a securities premium of Rs. [] per equity share (the Offer Price) aggregating to Rs. [] crores (the Offer). The offer comprises a fresh issue of [] equity shares of face value of Re.1/- by the company aggregating up to Rs. 800.00 crores (the Fresh Issue) and an offer for sale of up to 48,537,599 equity shares of face value of Re.1/- each aggregating to Rs.[] crores* comprising up to 19,088,670 equity shares of face value of Re.1/- each aggregating to Rs.[] crores by Iron Pillar PCC (Acting on behalf of Iron Pillar PCC - Cell C and Iron Pillar PCC - Cell E), up to 9,759,660 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Crimson Winter Limited, up to 4,575,330 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Accel India V (Mauritius) Limited, up to 3,666,020 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Chiratae Ventures India Fund IV, up to 3,524,213 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Global Ecommerce Consolidation Fund, I.P., up to 2,790,619 equity shares of face value of Re.1/- each aggregating to Rs.[] crores by Chiratae Ventures Master Fund iv, up to 1,431,150 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Alteria Capital Fund II -Scheme I, up to 1,281,510 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Curefit Healthcare Private Limited, up to 1,154,490 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Shripad Shrikrishna Nadkarni, up to 930,900 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Horizon Techno Pte. Ltd. and up to 335,037 equity shares of face value of Re. 1/- each aggregating to Rs.[] crores by Zephyr Peacock India Growth Fund (Collectively, the Selling Shareholders). The company, in consultation with the brlms, may consider a further issue of specified securities to certain investors for an amount aggregating up to Rs.160.00 crores, as permitted under applicable laws prior to the filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the scrr. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer, or the offer may be successful and will result into listing of the equity shares on the stock exchanges. further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). The face value of equity shares is Re.1/- each. The offer shall constitute []% of the post-offer paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company. * All or a certain portion of the offered shares of the selling shareholders includes equity shares that will be issued upon conversion of preference shares prior to the filing of the applicable.